Eric Y. Hung
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Toxicology 13
- Pharmacovigilance and Adverse Drug Reactions 13
-
- Venous Thromboembolism Diagnosis and Management 1
- Co-authors
- Manfred Hauben (16 shared papers)Francois M. Maignen (2 shared papers)Jean‐Michel Dogné (2 shared papers)Lionel Van Holle (2 shared papers)Huifeng Yun (1 shared paper)Jeffrey R. Curtis (1 shared paper)Ann M. Madsen (1 shared paper)Thomas V. Jones (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (4 papers)Therapeutic Advances in Drug Safety (3 papers)Clinical Therapeutics (2 papers)European Journal of Clinical Pharmacology (1 paper)Drug Safety (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Eric Y. Hung
16 papers receiving 375 citations
Peers
Comparison fields: 5 of 66
- Toxicology 167
- Internal Medicine 20
- Rheumatology 87
- Genetics 30
- Immunology 15
Countries citing papers authored by Eric Y. Hung
This map shows the geographic impact of Eric Y. Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Y. Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Y. Hung more than expected).
Fields of papers citing papers by Eric Y. Hung
This network shows the impact of papers produced by Eric Y. Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Y. Hung. The network helps show where Eric Y. Hung may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Y. Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 172 | |
| 2 | 2013 | 43 | |
| 3 | 2013 | 24 | |
| 4 | 2016 | 24 | |
| 5 | 2021 | 21 | |
| 6 | 2017 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2016 | 15 | |
| 9 | 2013 | 12 | |
| 10 | 2013 | 10 | |
| 11 | 2020 | 10 | |
| 12 | 2015 | 7 | |
| 13 | 2016 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2015 | 3 | |
| 16 | 2023 | 1 |
About Eric Y. Hung
Eric Y. Hung is a scholar working on Toxicology, Internal Medicine, Rheumatology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 386 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Rheumatoid Arthritis Research and Therapies (1 paper), Drug-Induced Adverse Reactions (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cardiovascular Conditions and Treatments (1 paper) and Diverticular Disease and Complications (1 paper). The work is most often cited by research in Toxicology (167 citations), Internal Medicine (20 citations), Rheumatology (87 citations), Genetics (30 citations) and Immunology (15 citations). Eric Y. Hung has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Manfred Hauben, Francois M. Maignen, Jean‐Michel Dogné, Lionel Van Holle, Huifeng Yun, Jeffrey R. Curtis, Ann M. Madsen, Thomas V. Jones, John C. Woolcott and Stanley B. Cohen. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Therapeutic Advances in Drug Safety, Clinical Therapeutics, European Journal of Clinical Pharmacology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.